Comparison of staging systems of hepatocellular carcinoma - Wikidata - wikimedia - TriplyDB

Comparison of staging systems of hepatocellular carcinoma

Comparison of staging systems of hepatocellular carcinoma

http://www.wikidata.org/entity/Q35094309

about

Staging of hepatocellular carcinoma Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems.MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3.Evaluation of eight different clinical staging systems associated with overall survival of chinese patients with hepatocellular carcinoma.Treatment of hepatocellular carcinoma: a systematic review.Thrombocytosis as a prognostic marker in gastrointestinal cancers.Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems.Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?

P2860

Q28081265-C82A270C-1C44-4F0D-97A4-395D7CBC5667 Q34061430-03FF4B30-21EC-4EE6-A713-F1206942E028 Q35013542-0FBDCB02-E78D-418B-8169-4E1798F914C0 Q36816413-BB70D172-E6FC-4411-A886-A888E895AD63 Q38155508-0185540D-5434-46CF-867D-12EC041B9312 Q38190956-FECA340E-9184-4FD1-858E-49892AF50C07 Q38883230-AF2C43D5-0A11-4253-811C-5988C57A54C1 Q47328128-474CFBED-8901-43E4-8729-A4334571B49E Q58806088-AA7F59A8-CCE4-44A0-B23D-DAC137F29175

P2860

Comparison of staging systems of hepatocellular carcinoma

http://www.wikidata.org/entity/Q35094309

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Comparison of staging systems of hepatocellular carcinoma

@ast

Comparison of staging systems of hepatocellular carcinoma

@en

type

label

Comparison of staging systems of hepatocellular carcinoma

@ast

Comparison of staging systems of hepatocellular carcinoma

@en

prefLabel

Comparison of staging systems of hepatocellular carcinoma

@ast

Comparison of staging systems of hepatocellular carcinoma

@en

P1433

Q35094309-C64523E7-F584-48DF-9B8E-3B18B20BBB40

P1476

Q35094309-ADFA9E05-FACB-4298-AA48-5B99884A1FF1

P2093

Q35094309-61371BEF-3CAD-4706-B106-29F7E70EC695

Q35094309-7A05692F-7709-4C89-A3D4-9541879278D6

P2860

Q35094309-02711DDE-D866-473B-A825-514333FCAAE3

Q35094309-0E473CBE-80E5-4C18-B856-74C21D6F82F9

Q35094309-2BF55EAD-619A-4CBE-8B9A-AD9AA8634139

Q35094309-2C3DCE79-83D3-4D39-A09F-39A9EA55E00B

Q35094309-392105D4-21F0-4BAB-B9AD-142F6EBCCAE2

Q35094309-3C5C29EF-7033-4E06-B54D-78AF5691EAF5

Q35094309-4366A53A-5E0D-4C17-81D9-99EA6DE729D7

Q35094309-43C55960-9344-4C91-8CF9-4CD74D6DB686

Q35094309-4E77F093-ED8C-44BD-9ED1-61A34C7B3843

Q35094309-56C26096-8B8B-40C0-A7ED-F7A640D4EC85

P304

Q35094309-49B33D26-9A35-4DB1-B480-DD7609405D32

P31

Q35094309-0788C7BC-CE4D-4C2C-A815-B023AA8B91FD

P356

Q35094309-44E16206-1F2D-4B3E-ABAA-2EC8620CA7D3

P478

Q35094309-CCA11C50-FE06-46FF-BA00-874B49714EFB

P50

Q35094309-398FB551-74C8-48F2-A408-37AF4F84581C

Q35094309-D2922B9A-3D0E-438A-AE99-5CCEEABCCDBF

P577

Q35094309-5645A228-4EE1-40A8-A605-8E572540BDEF

P5875

Q35094309-67FCCD53-0019-474E-85AB-366C9DF97C66

P698

Q35094309-31115B2F-8A78-4435-ABDB-A29EFC2FDD08

P932

Q35094309-02874DD0-D324-43C2-9774-AC5567CE84B9

P356

P1433

HPB surgery : a world journal of hepatic, pancreatic and biliary surgery

P1476

Comparison of staging systems of hepatocellular carcinoma

@en

P2093

Chutwichai Tovikkai

http://www.w3.org/2001/XMLSchema#string

Yongyut Sirivatanauksorn

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study.

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.

Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Critical evaluation of the different staging systems for hepatocellular carcinoma.

Clinical presentation and natural course of hepatocellular carcinoma.

Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.

AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement.

P304

818217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/818217

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P50

Yongyut Sirivatanauksorn

P577

2011-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51494012

http://www.w3.org/2001/XMLSchema#string

P698

21760664

http://www.w3.org/2001/XMLSchema#string

P932

3132503

http://www.w3.org/2001/XMLSchema#string